Simplex Trading’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-648
Closed -$66K 9761
2023
Q1
$66K Buy
648
+630
+3,500% +$119K ﹤0.01% 5618
2022
Q4
$2K Sell
18
-42
-70% -$18.2K ﹤0.01% 8630
2022
Q3
$30K Buy
60
+58
+2,900% +$50.5K ﹤0.01% 7084
2022
Q2
$1K Sell
2
-5
-71% -$6.86K ﹤0.01% 9650
2022
Q1
$16K Sell
7
-12
-63% -$28.5K ﹤0.01% 8477
2021
Q4
$48K Sell
19
-13
-41% -$52K ﹤0.01% 7320
2021
Q3
$231K Hold
32
﹤0.01% 5368
2021
Q2
$222K Buy
+32
New +$221K ﹤0.01% 5525
2021
Q1
Hold
0
4812
2020
Q3
Hold
0
-$16K 8371
2020
Q2
Hold
0
6376
2020
Q1
Hold
0
6866
2019
Q4
Hold
0
5522
2019
Q3
Hold
0
4423
2019
Q2
Hold
0
5393
2019
Q1
Hold
0
5312
2018
Q4
Hold
0
5132
2018
Q3
Hold
0
7220
2018
Q2
Hold
0
6412

Other funds holding RDHL

Simplex Trading's RDHL Position: Q1 2023 in Review

Simplex Trading sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 8 shares — an estimated $1.51K sold.

Simplex Trading first reported a position in RDHL in Q4 2019 and held it in 12 quarters. The position peaked at $224K in Q2 2020. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Simplex Trading reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Simplex Trading sold 8 Redhill Biopharma shares in Q1 2023, an estimated $1.51K.
  • Simplex Trading first reported a position in Redhill Biopharma in Q4 2019 and held it in 12 quarters.
  • Simplex Trading's Redhill Biopharma position peaked at $224K in Q2 2020.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.